Literature DB >> 29409856

Crocin mediated amelioration of oxidative burden and inflammatory cascade suppresses diabetic nephropathy progression in diabetic rats.

Hadeer O Abou-Hany1, Hoda Atef2, Eman Said3, Hassan A Elkashef4, Hatem A Salem5.   

Abstract

Diabetic Nephropathy (DN) is one of the main complications associated with diabetes mellitus. Persistently elevated blood glucose level drives histopathological changes in renal tissues that hinder normal kidney functions. In the current study, crocin; the main bioactive constituent of Crocus sativus was investigated as a reno-protective agent against DN by virtue of its numerous pharmacological activities. Diabetes was induced in male Sprague-Dawely rats through intravenous injection of streptozocin (STZ) (50 mg/kg), DN was confirmed eight weeks post diabetes induction. Daily oral crocin for eight weeks (20 mg/kg) significantly reduced blood glucose level with a significant increase in insulin level. Moreover, crocin improved impaired kidney functions as manifested in reduction of serum creatinine levels, blood urea nitrogen and proteinuria with concomitant increase in urinary creatinine clearance. Furthermore, biomarkers of cell injury and tissue necrosis like LDH activity was significantly reduced, kidney content of NOS significantly declined likewise. In addition, renal antioxidants such as SOD, GSH and serum catalase activity significantly increased with concomitant reduction of kidney MDA; biomarker of oxidative load. Kidney content of toll-like receptors 4 and IL-6 significantly declined with simultaneous suppression of nuclear factor kappa-B (NF-κB/p65) protein expression and immuno-staining in rat renal cortex. Furthermore, crocin inhibited progression of renal fibrosis as seen with reduction of renal hydroxyproline and collagen content, TGF-β immuno-staining and Masson's Trichrome positive tissue. Histopathologically, crocin pretreatment was associated with minimal renal damage with fewer fibrotic lesions. There was a concomitant restoration of renal tubules integrity with preservation of glomerular space area. In conclusion, crocin's ameliorative impact on DN may be attributed to its free radicals scavenging properties, its ability to enhance host antioxidant defense system and its ability to inhibit inflammatory and fibrotic cascades activation.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Crocin; DN; IL-6; Insulin; ROS; TLR-4

Mesh:

Substances:

Year:  2018        PMID: 29409856     DOI: 10.1016/j.cbi.2018.02.001

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  20 in total

1.  Evaluation of the Effect of Crocin on Doxorubicin-Induced Cardiotoxicity.

Authors:  Parisa Esmaili Motlagh; Arefeh Ghafari Novin; Fatemeh Ghahari; Amin Nikzad; Mohadeseh Khoshandam; Saba Mardani; Hashem Khanbabaei; Alireza Farsinejad; Thozhukat Sathyapalan; Amirhossein Sahebkar; Hossein Pourghadamyari
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Saffron as a promising therapy for diabetes and Alzheimer's disease: mechanistic insights.

Authors:  Sarvin Sanaie; Saba Nikanfar; Zahra Yousefi Kalekhane; Akbar Azizi-Zeinalhajlou; Saeed Sadigh-Eteghad; Mostafa Araj-Khodaei; Mohammad Hossein Ayati; Sasan Andalib
Journal:  Metab Brain Dis       Date:  2022-08-20       Impact factor: 3.655

3.  The effect of crocin supplementation on glycemic control, insulin resistance and active AMPK levels in patients with type 2 diabetes: a pilot study.

Authors:  Vahideh Behrouz; Ali Dastkhosh; Mehdi Hedayati; Meghdad Sedaghat; Maryam Sharafkhah; Golbon Sohrab
Journal:  Diabetol Metab Syndr       Date:  2020-07-09       Impact factor: 3.320

Review 4.  The effects of saffron supplementation on the measures of renal function indicators: a systematic review and meta-analysis.

Authors:  Abdolreza Norouzy; Sara Ghodrat; Leila Sadat Bahrami; Zahra Feizy; Seyyed Mostafa Arabi
Journal:  Int Urol Nephrol       Date:  2022-02-01       Impact factor: 2.266

5.  Attenuation of Diabetic Nephropathy in Diabetic Mice by Fasudil through Regulation of Macrophage Polarization.

Authors:  Fajiang Xie; Jiesen Lei; Maoxia Ran; Yan Li; Li Deng; Jian Feng; Yi Zhong; Jiafu Li
Journal:  J Diabetes Res       Date:  2020-06-30       Impact factor: 4.011

Review 6.  Saffron (Crocus sativus L.) in Ocular Diseases: A Narrative Review of the Existing Evidence from Clinical Studies.

Authors:  Rebekka Heitmar; James Brown; Ioannis Kyrou
Journal:  Nutrients       Date:  2019-03-18       Impact factor: 5.717

7.  Mesenchymal Stem Cell-Derived Exosomes Ameliorated Diabetic Nephropathy by Autophagy Induction through the mTOR Signaling Pathway.

Authors:  Nesrine Ebrahim; Inas A Ahmed; Noha I Hussien; Arigue A Dessouky; Ayman Samir Farid; Amal M Elshazly; Ola Mostafa; Walaa Bayoumie El Gazzar; Safwa M Sorour; Yasmin Seleem; Ahmed M Hussein; Dina Sabry
Journal:  Cells       Date:  2018-11-22       Impact factor: 6.600

8.  Protective Effect of Hydroxysafflor Yellow A on Nephropathy by Attenuating Oxidative Stress and Inhibiting Apoptosis in Induced Type 2 Diabetes in Rat.

Authors:  Maosheng Lee; Hengxia Zhao; Xuemei Liu; Deliang Liu; Jianping Chen; Zengying Li; Shufang Chu; Xinhui Kou; Si Liao; Yuxiu Deng; Huilin Li; Weidong Xie
Journal:  Oxid Med Cell Longev       Date:  2020-03-11       Impact factor: 6.543

9.  Effect of crocin on antioxidant gene expression, fibrinolytic parameters, redox status and blood biochemistry in nicotinamide-streptozotocin-induced diabetic rats.

Authors:  Ioannis Margaritis; Katerina Angelopoulou; Sophia Lavrentiadou; Ilias C Mavrovouniotis; Maria Tsantarliotou; Ioannis Taitzoglou; Alexandros Theodoridis; Aristidis Veskoukis; Efthalia Kerasioti; Dimitrios Kouretas; Ioannis Zervos
Journal:  J Biol Res (Thessalon)       Date:  2020-03-02       Impact factor: 1.889

10.  Protective Effect of Ginkgo biloba and Magnetized Water on Nephropathy in Induced Type 2 Diabetes in Rat.

Authors:  Ahmed E Zayed; Ahmed Saleh; Asmaa M S Gomaa; Mahmoud Abd-Elkareem; Mamdouh M Anwar; Khaled M A Hassanein; Mohsen M Elsherbiny; Ahmed M Kotb
Journal:  Oxid Med Cell Longev       Date:  2018-06-11       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.